Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Pediatric Cardiology

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1659417

Retrograde Transarterial Closure of Small Aneurysmal Perimembranous Ventricular Septal Defects Using the Amplatzer Duct Occluder II: A Single-Center Mid-Term Analysis

Provisionally accepted
Sibao  WangSibao Wang1*Gang  LuoGang Luo1Zhixian  JiZhixian Ji2Silin  PanSilin Pan2*
  • 1Qingdao University, Qingdao, China
  • 2Qingdao Women and Children's Hospital, Qingdao, China

The final, formatted version of the article will be published soon.

Background: Transcatheter closure of aneurysmal perimembranous ventricular septal defects (pmVSDs) presents distinct anatomical challenges. While the retrograde transarterial approach using the Amplatzer Duct Occluder II (ADO II) has been described, data focusing on mid-term outcomes in this specific patient population remain limited. Methods: We conducted a single-center, retrospective analysis of pediatric patients with hemodynamically significant small aneurysmal pmVSDs who underwent transcatheter closure via a retrograde approach with the ADO II device. Primary endpoints included procedural success, complications, and mid-term clinical and echocardiographic outcomes. Results: Twenty-seven patients (median age 3.6 years; median weight 15.9 kg) were included. Defects had a median left ventricular inlet diameter of 4.0 mm and right ventricular outlet diameter of 2.7 mm; 59.3% were saccular aneurysms. The procedure was successful in 100% of cases using ADO II devices ranging from 4-4 to 6-6 mm. Median fluoroscopy time was 8.6 minutes. No major procedural complications occurred. The immediate complete closure rate was 85.2%, rising to 100% at a median follow-up of 49 months, with resolution of all clinical symptoms and no late device-related adverse events. Conclusion: Retrograde transarterial closure of small aneurysmal pmVSDs with the ADO II device is a feasible, safe, and effective therapeutic strategy in appropriately selected pediatric patients.

Keywords: Ventricular septal defect, Aneurysmal, Catheterization, Amplatzer duct occluder II, retrograde transarterial approach

Received: 04 Jul 2025; Accepted: 25 Sep 2025.

Copyright: © 2025 Wang, Luo, Ji and Pan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Sibao Wang, mousdoor@163.com
Silin Pan, silinpa@126.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.